KPP
PAHC icon

Kings Path Partners’s Phibro Animal Health PAHC Stock Holding History

Kings Path Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Hold
17,155
– – 0.14% 63
2026
Q1 		$949K Hold
17,155
– – 0.33% 36
2025
Q4 		$641K Hold
17,155
– – 0.22% 46
2025
Q3 		$694K Sell
17,155
-3,445
-17% -$114K 0.26% 41
2025
Q2 		$526K Buy
20,600
+9,600
+87% +$209K 0.21% 55
2025
Q1 		$235K Buy
+11,000
New +$246K 0.12% 90

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Kings Path Partners's PAHC Position: Q2 2026 in Review

Kings Path Partners held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 17,155 shares worth $539K. The position accounts for 0.14% of the portfolio, ranked #63.

Kings Path Partners first reported a position in PAHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $949K in Q1 2026. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Kings Path Partners held 17,155 shares of Phibro Animal Health worth $539K as of Q2 2026.
  • Kings Path Partners left its Phibro Animal Health share count unchanged in Q2 2026.
  • Phibro Animal Health made up 0.14% of Kings Path Partners's portfolio in Q2 2026, its #63 holding.
  • Kings Path Partners first reported a position in Phibro Animal Health in Q1 2025 and has held it in 6 quarters since.
  • Kings Path Partners's Phibro Animal Health position peaked at $949K in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.